Core Laboratories N.V.

NYSE:CLB

Oil & Gas Equipment & Services

Energy
$8.45 +1.01%

+$0.12 today

Market cap
$387.21M
Beta
0.99
P/E (TTM)
18.3
EPS (TTM)
$0.63
Dividend yield
0.35%
52W Low $9.72High $20.36

Volume 0.52M

Average 0.49M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$37.18M

FY 2025 · Annual

-34.1% YoY

Investing Cash Flow

-$2.23M

FY 2025 · Annual

Financing Cash Flow

-$31.25M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income20.22M19.66M37.03M32.15M31.8M
Depreciation & Amortization18.52M17.16M15.78M14.95M14.65M
Deferred Income Tax6.01M433K(10.81M)674K(4.74M)
Stock-Based Compensation19.09M7.76M13.97M3.76M7.14M
Change in Working Capital(24.25M)(25.02M)(28.77M)7.88M(5.57M)
Accounts Receivables(13.52M)(10.08M)(2.62M)(3.61M)(4.95M)
Inventory(4.55M)(14.86M)(12.98M)9.37M2.64M
Accounts Payables6.57M15.37M(12.88M)519K477K
Other Working Capital(12.75M)(15.46M)(300K)1.61M(3.73M)
Other Non-Cash Items(3.01M)4.97M(2.41M)(3.03M)(6.11M)
Operating Cash Flow36.58M24.96M24.79M56.39M37.18M
Capital Expenditures(13.54M)(10.22M)(10.58M)(13.03M)(14.59M)
Acquisitions (Net)873K240K00(1.24M)
Purchases of Investments13.54M0000
Sales of Investments726K0000
Other Investing Activities(11.82M)6.12M3.93M6.63M13.6M
Investing Cash Flow(10.22M)(3.86M)(6.65M)(6.39M)(2.23M)
Debt Repayment(71M)(15M)(9M)(38M)(16.71M)
Common Stock Issued60M0000
Common Stock Repurchased(8.26M)(3.9M)(2.2M)(5.31M)(12.43M)
Dividends Paid(1.83M)(1.85M)(1.87M)(1.88M)(1.87M)
Other Financing Activities(1.37M)(2.62M)(5.38M)(775K)(254K)
Financing Cash Flow(22.46M)(23.38M)(18.45M)(45.96M)(31.26M)
Effect of Forex Changes00000
Net Change in Cash3.9M(2.28M)(308K)4.04M3.69M
Free Cash Flow23.04M14.74M14.21M43.36M22.59M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$31.8M
+ D&A$14.6M
+ Stock-Based Comp$7.1M
- Deferred Tax-$4.7M
- Working Capital-$5.6M
- Other Non-Cash-$6.1M
= Operating Cash Flow$37.2M
- Capex-$14.6M
= Free Cash Flow$22.6M

Analysis

FY2025 free cash flow is $22.6M. FCF conversion is 71.0% of net income. Operating cash flow was $37.2M, with capex of -$14.6M. The largest bridge item is D&A at $14.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportOct 30, 2026
8-KCurrent reportOct 28, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
4Statement of changes in beneficial ownershipOct 5, 2026

Does CLB generate free cash flow?

Core Laboratories N.V. (CLB) generated $22.59M of free cash flow in fiscal 2025.

How much operating cash flow does CLB produce?

Operating cash flow was $37.18M, before capital expenditures of $14.59M.